Resources
Home|Resources

Resources

Our Resources include public comments, presentations, proceedings, articles and publications, reports and guidance documents, templates, and training materials.

For Sponsor Only Resources, available to registered sponsors, please login here first.

  • Focus Area

  • Projects

  • Type

  • Filter by Language

Type
Resource
Project
  • Publication
September 5, 2023
Defining “recklessness” in research misconduct proceedings
Advancing the Quality of Clinical Trial Enterprise
  • Publication
August 29, 2023
The Unresolved Challenge of Triage
Advancing the Quality of Clinical Trial Enterprise , Global Regulatory Engagement
  • Public Comments
July 30, 2023
Response to the proposed revision of the EU general pharmaceuticals legislation
Advancing the Quality of Clinical Trial Enterprise , Global Regulatory Engagement , Promoting Global Clinical Research in Children
  • Public Comments
July 5, 2023
Response Letter to NIH Request for Information (RFI) on the Updated Policy Guidance for Subaward/Consortium Written Agreements
Advancing the Quality of Clinical Trial Enterprise
  • Public Comments
June 30, 2023
Response to Institute for Clinical and Economic Review (ICER) re: Proposed Changes to the 2023 Value Assessment Framework
Advancing the Quality of Clinical Trial Enterprise
  • Publication
May 25, 2023
Bringing data monitoring committee charters into the sunlight
Advancing the Quality of Clinical Trial Enterprise
  • Publication
April 18, 2023
How To Limit Uninformative Trials: Results From A Delphi Working Group
Advancing the Quality of Clinical Trial Enterprise
  • Publication
April 4, 2023
Disclosure of Possible Trial Termination to Participants of Interventional Clinical Trials
Advancing the Quality of Clinical Trial Enterprise
  • Publication
March 30, 2023
Comparison of Availability of Trial Results in ClinicalTrials.gov and PubMed
Advancing the Quality of Clinical Trial Enterprise
  • Publication
January 4, 2023
Ensuring the Scientific Value and Feasibility of Clinical Trials
Advancing the Quality of Clinical Trial Enterprise
  • Publication
December 15, 2022
Allocation of Opportunities to Participate in Clinical Trials during the Covid-19 Pandemic and Other Public Health Emergencies
Advancing the Quality of Clinical Trial Enterprise
  • Annual Report
December 15, 2022
2022 MRCT Center Annual Report
Advancing the Quality of Clinical Trial Enterprise , Data Sharing , Diversity, Inclusion, and Equity in Clinical Research , Health Literacy in Clinical Research , Post-Trial Responsibilities , Promoting Global Clinical Research in Children , Oversight and Implementation of Decentralized Clinical Trials , Bioethics Collaborative , Research, Development, & Regulatory Roundtable (R3) , Return of Aggregate Results , Return of Individual Results
  • Publication
November 18, 2022
Characterization of Informed Consent Forms Posted on ClinicalTrials.gov.
Advancing the Quality of Clinical Trial Enterprise
  • Publication
August 17, 2022
The proportion of randomized controlled trials that inform clinical practice
Advancing the Quality of Clinical Trial Enterprise
  • Publication
June 10, 2022
Approach For Reporting Master Protocol Study Designs on ClinicalTrials.gov: Qualitative Analysis
Advancing the Quality of Clinical Trial Enterprise
  • Publication
April 8, 2022
Completeness of clinical evidence citation in trial protocols: A cross-sectional analysis, published in Clinical and Translational Report
Advancing the Quality of Clinical Trial Enterprise
  • Publication
February 25, 2022
Reporting of Clinical Trial Results: Aligning Incentives and Requirements to Do the Right Thing in Clinical Therapeutics
Advancing the Quality of Clinical Trial Enterprise
  • Podcast
January 24, 2022
Drug Researchers Refuse To Follow The Law. The Government Isn’t Stopping Them
Advancing the Quality of Clinical Trial Enterprise
  • Publication
January 4, 2022
Complete, Rapid Reporting of Clinical Trials: A Necessary Component of the Pandemic Response
Advancing the Quality of Clinical Trial Enterprise
  • Annual Report
December 7, 2021
2021 MRCT Center Impact Report
Advancing the Quality of Clinical Trial Enterprise , Data Sharing , Diversity, Inclusion, and Equity in Clinical Research , Return of Individual Results , Promoting Global Clinical Research in Children , Research, Development, & Regulatory Roundtable (R3) , Bioethics Collaborative
  • Publication
September 1, 2021
Monitoring the Pediatric Clinical Trials Enterprise
Advancing the Quality of Clinical Trial Enterprise , Promoting Global Clinical Research in Children
  • Publication
July 31, 2021
Genomic Epidemiology Data Infrastructure Needs for SARS-CoV-2
Advancing the Quality of Clinical Trial Enterprise
  • Publication
May 24, 2021
Trial Reporting and the Clinical Trials Enterprise
Advancing the Quality of Clinical Trial Enterprise
  • Publication
December 15, 2020
Lack of harmonization of coronavirus disease ordinal scales
Advancing the Quality of Clinical Trial Enterprise
  • Publication
November 3, 2020
Critics say new NIH policy on scientific data sharing falls short
Advancing the Quality of Clinical Trial Enterprise
  • Public Comments
June 29, 2020
Response to FDA’s request for comments on strategic priorities for the Office of Minority Health and Health Equity (OMHHE)
Advancing the Quality of Clinical Trial Enterprise
  • Publication
April 1, 2020
Diagnostic Testing for COVID-19: Considering False Positive and False Negative Results by Deborah A. Zarin, MD, MRCT Center Program Director and Joseph Lau, MD
Advancing the Quality of Clinical Trial Enterprise
  • Publication
March 20, 2020
Time for NIH to lead on data sharing
Advancing the Quality of Clinical Trial Enterprise
  • Publication
January 20, 2020
Issues in the registration of database studies
Advancing the Quality of Clinical Trial Enterprise
  • Annual Report
December 4, 2019
2019 MRCT Center Impact Report
Global Regulatory Engagement , Real World Evidence , Impact of Privacy Laws on Clinical Research , Promoting Global Clinical Research in Children , Health Literacy in Clinical Research , Diversity, Inclusion, and Equity in Clinical Research , Bioethics Collaborative , Research, Development, & Regulatory Roundtable (R3) , Proactive Safety Surveillance: A Global Approach , Data Sharing , Advancing the Quality of Clinical Trial Enterprise , Training & Education , Joint Task Force for Clinical Trial Competency
  • Publication
November 14, 2019
10-Year Update on Study Results Submitted to ClinicalTrials.gov
Advancing the Quality of Clinical Trial Enterprise
  • Publication
October 28, 2019
The Culture of Trial Results Reporting at Academic Medical Centers
Advancing the Quality of Clinical Trial Enterprise
  • Publication
September 1, 2019
Trial Effort: Deborah Zarin on Clinical Decision Making and Building a Database for Clinical Trial Results
Advancing the Quality of Clinical Trial Enterprise
  • Publication
August 20, 2019
Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey
Advancing the Quality of Clinical Trial Enterprise
  • Publication
July 25, 2019
Harms From Uninformative Clinical Trials
Advancing the Quality of Clinical Trial Enterprise
  • MRCT Sponsor Resource
December 5, 2018
MRCT Center 2018 Annual Meeting Slides
Impact of Privacy Laws on Clinical Research , Advancing the Quality of Clinical Trial Enterprise , Health Literacy in Clinical Research